Intellia Therapeutics Inc (NTLA)

NASDAQ · Biotechnology

12.73
+0.00 (+0.00%)
Updated Sep 1, 7:28 PM ET
AI Rating
Hold
Overall Score
59
Trend
53
Momentum
78
Risk
42

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

Intellia Therapeutics Inc is trading at $12.73, up 0.00% on the session. The 50 day average sits at $13.21 and the 200 day at $12.46, which puts the stock in a uptrend. RSI is at 53.4, which reads as neutral, and MACD is bullish crossover. Volume is average.

The nearest support is around $11.81 with resistance near $13.35, so that band frames the current range. Average daily movement is roughly $0.74, or about 5.8% of the share price, which is what any stop placement has to allow for. The overall health score of 59 out of 100 combines a trend score of 53, momentum of 78 and a risk score of 42.

Technical indicators

RSI (14)
53.4
neutral
MACD
0.181
bullish crossover
SMA 20
12.18
SMA 50
13.21
SMA 200
12.46
uptrend
ATR (14)
0.74
avg daily range
Support
11.81
Resistance
13.35
Volume vs 20d
1.00x
average
Volatility
71.8%
annualised
1 month
+16.05%
3 months
-8.53%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.